276 related articles for article (PubMed ID: 29684566)
1. Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.
Busca A; Dellacasa C; Giaccone L; Manetta S; Biale L; Godio L; Aydin S; Festuccia M; Brunello L; Bruno B
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1765-1770. PubMed ID: 29684566
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Gao Y; Gao F; Shi J; Fu H; Huang H; Zhao Y
J Zhejiang Univ Sci B; 2021 Aug; 22(8):695-700. PubMed ID: 34414703
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
Cao J; Lu S; Luo D; Pei R; Lu Y; Chen D; Du X; Li S
Transfusion; 2024 Mar; 64(3):510-516. PubMed ID: 38351735
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
Helbig G; Stella-Holowiecka B; Krawczyk-Kulis M; Wojnar J; Markiewicz M; Wojciechowska-Sadus M; Kopera M; Kruzel T; Najda J; Nowak K; Holowiecki J
Haematologica; 2005 Nov; 90 Suppl():ECR33. PubMed ID: 16266924
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant.
Sackett K; Cohn CS; Fahey-Ahrndt K; Smith AR; Johnson AD
J Clin Apher; 2018 Feb; 33(1):108-112. PubMed ID: 28543448
[TBL] [Abstract][Full Text] [Related]
6. Eltrombopag restores erythropoiesis in refractory adult acquired pure red cell aplasia.
Liu X; Cheng L; He Y; Zhang R; Lu R; Zhang J; Hong M; He G; Li J
Int J Hematol; 2021 Jul; 114(1):124-128. PubMed ID: 33611753
[TBL] [Abstract][Full Text] [Related]
7. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
[TBL] [Abstract][Full Text] [Related]
8. [Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Fan H; Jing Y; Li HH; Lu XC; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):364-7. PubMed ID: 18426666
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant.
Vivero A; Peedin AR; Gao Y; Karp JK
J Clin Apher; 2023 Aug; 38(4):495-499. PubMed ID: 36703597
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Zhu KE; Li JP; Zhang T; Zhong J; Chen J
Hematology; 2007 Apr; 12(2):117-21. PubMed ID: 17454192
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia.
Jeyaraman P; Borah P; Rajput P; Dayal N; Pathak S; Naithani R
Blood Cells Mol Dis; 2021 May; 88():102464. PubMed ID: 32653327
[TBL] [Abstract][Full Text] [Related]
12. Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review.
Yang MH; Hsu HC
Ann Hematol; 2001 May; 80(5):299-301. PubMed ID: 11446734
[TBL] [Abstract][Full Text] [Related]
13. [Pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation].
Huang XJ; Liu DH; Xu LP; Han W; Jiang Q; Chen YH; Zhang YC; Liu KY; Bao L; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):548-50. PubMed ID: 16468333
[TBL] [Abstract][Full Text] [Related]
14. Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G; Stella-Holowiecka B; Wojnar J; Krawczyk M; Krzemien S; Wojciechowska-Sadus M; Markiewicz M; Wylezol I; Kopera M; Holowiecki J
Ann Hematol; 2007 Sep; 86(9):677-83. PubMed ID: 17486341
[TBL] [Abstract][Full Text] [Related]
15. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation.
Fang B; Song Y; Li N; Li J; Han Q; Zhao RC
Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919
[TBL] [Abstract][Full Text] [Related]
17. Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
Marco-Ayala J; Gómez-Seguí I; Sanz G; Solves P
Bone Marrow Transplant; 2021 Apr; 56(4):769-778. PubMed ID: 33188257
[TBL] [Abstract][Full Text] [Related]
18. Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Rabitsch W; Knöbl P; Prinz E; Keil F; Greinix H; Kalhs P; Worel N; Jansen M; Hörl WH; Derfler K
Bone Marrow Transplant; 2003 Nov; 32(10):1015-9. PubMed ID: 14595389
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.
Zhu P; Wu Y; Cui D; Shi J; Yu J; Zhao Y; Lai X; Liu L; Xie J; Huang H; Luo Y
Front Immunol; 2022; 13():829670. PubMed ID: 35222414
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.
Tang C; Chen F; Kong D; Ma Q; Dai H; Yin J; Li Z; Chen J; Zhu X; Mao X; Wu D; Tang X
J Hematol Oncol; 2018 Aug; 11(1):103. PubMed ID: 30115080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]